Allen Capital Group LLC Increases Position in Danaher Co. (NYSE:DHR)

Allen Capital Group LLC lifted its position in shares of Danaher Co. (NYSE:DHR) by 24.3% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 1,519 shares of the conglomerate’s stock after buying an additional 297 shares during the period. Allen Capital Group LLC’s holdings in Danaher were worth $422,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher during the second quarter worth approximately $25,000. nVerses Capital LLC purchased a new position in Danaher during the second quarter worth approximately $25,000. MidAtlantic Capital Management Inc. purchased a new position in Danaher during the third quarter worth approximately $40,000. MFA Wealth Advisors LLC purchased a new position in Danaher during the second quarter worth approximately $51,000. Finally, Financial Connections Group Inc. purchased a new position in Danaher during the second quarter worth approximately $51,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Activity

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at approximately $1,130,374.44. The trade was a 18.44 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of DHR stock opened at $235.83 on Friday. The firm has a market cap of $170.33 billion, a P/E ratio of 45.01, a P/E/G ratio of 4.25 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70. The firm has a fifty day moving average of $258.15 and a two-hundred day moving average of $259.88.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The company had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period last year, the business earned $2.02 EPS. As a group, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. Danaher’s payout ratio is currently 20.61%.

Analysts Set New Price Targets

Several research firms have recently issued reports on DHR. Raymond James dropped their price objective on shares of Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Barclays dropped their price objective on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 23rd. Stifel Nicolaus increased their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Finally, Robert W. Baird dropped their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.